|
Summary
|
Covers
SEC practice of reviewing filings
to elicit improved disclosure
- By sending comment letters
- For many years SEC focused on
registration statement disclosures
- Especially Form S-1s used in IPOs
- SEC wouldn't accelerate effectiveness until
its comments were adequately addressed
With
recent changes, SEC is giving greater attention
to Exchange Act filings
- Requires SEC to periodically review
an issuer's Exchange Act reports
- See SEC's Fortune 500 survey
- Securities Offering Reform changes (2005)
SEC
has begun releasing its comment letters
|
Disclosure of Unresolved SEC Comments
|
SEC
requires disclosure of unresolved SEC comments
- Requires disclosure in Form 10-K / Form 20-F
Issuer
must disclose comments that:
- Were made as part of a review of an Exchange Act
report
- Issuer believes are material
- Remain unresolved as of the date of the filing
- Were issued more than 180 days before the end of
the fiscal year covered by the annual report
- Prior to 7.05, for 12.31 FYE companies
- Measured from date the SEC Staff originally made
the comment
Adopted
as part of Securities Offering Reform
|
Precedent Form 10-K Item 1B Disclosures
|
Unresolved
SEC comments
No
unresolved SEC comments
|
Recent 10-K Amendments - Response to SEC Comments
SEC_CODE_REF_0090001192884
|
Due
to SEC review and comments
- Amends Item 9A disclosures in response to SEC
comment
- Amends Item 9A disclosures in response to SEC
comment
- Amends Item 9A disclosures in response to SEC
comment
- Amends Item 9A disclosures in response to SEC
comment
- To amend Item 9A disclosures
- Changes in response to SEC comments
on going private transaction
- Amended 10-K is incorporated by reference
- To amend Item 9A disclosures
- Changes to MD&A in response to SEC comments
- Revised MD&A section
- Changes in response to SEC comments
- Disclosure of backlog orders
- Expanded disclosures about internal controls
- Changes to wording of CEO-CFO certifications
- Changes to MD&A in response to SEC comments
- Arose in context of Oracle's acquisition of
PeopleSoft
- Revised MD&A section
|
Other Precedent Disclosures
|
Corporate
action in response to SEC comment letters
- Form 10-K/A
(1.13.06)
- Restatement followed SEC comment letter about
treatment of cash flows for rental assets
|
M&A Agreement Representations
|
Inamed
- Allergan (2005)
Linens
N Things LBO (2005)
|
Related Topics
|